An innovative method for assessing autophagy using the FlowSight imaging flow cytometer
-
1
Amnis part of EMD Millipore, Amnis Biology, United States
Autophagy is a process in which normal cellular components that accumulate during growth and differentiation are degraded via the lysosome; it is a survival mechanism that reallocates nutrients from unnecessary processes to more vital processes in the cell. Basal levels of autophagy are usually low but can be up-regulated by numerous stimuli including starvation, physiological stress, pharmacological agents and infections. In addition, suppression of autophagy has been associated with cancer, neurodegenerative disorders, infectious diseases and inflammation. During autophagy, cytoplasmic LC3 is processed and recruited to the autophagosomal membranes; therefore, cells undergoing autophagy can be identified by visualizing LC3 puncta using immunofluorescence microscopy. While manual microscopy allows visual identification of autophagy on a per-cell basis, an objective and statistically rigorous assessment is difficult to obtain. To overcome these problems, we used the FlowSight imaging cytometry platform collect imagery of large numbers of cells to assess autophagy in an objective, quantitative, and statistically robust manner. In this study, we demonstrate a method for determining the best image-based parameter for assess the LC3 puncta in starved and non-starved U2OS RFP-LC3 human osteosarcoma reporter cells.
Keywords:
Autophage,
FlowSight,
LC3,
Imaging cytometry,
Amnis
Conference:
15th International Congress of Immunology (ICI), Milan, Italy, 22 Aug - 27 Aug, 2013.
Presentation Type:
Abstract
Topic:
Innate immunity
Citation:
Pugsley
HR,
Kong
R,
Friend
SL,
Hall
BE,
Basiji
DA and
Morrissey
P
(2013). An innovative method for assessing autophagy using the FlowSight imaging flow cytometer.
Front. Immunol.
Conference Abstract:
15th International Congress of Immunology (ICI).
doi: 10.3389/conf.fimmu.2013.02.01067
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
09 Jul 2013;
Published Online:
22 Aug 2013.
*
Correspondence:
Dr. Haley R Pugsley, Amnis part of EMD Millipore, Amnis Biology, Seattle, Washington, 98119, United States, haley.pugsley@emdmillipore.com